Advanced search
Publication Cover
Scandinavian Journal of Primary Health Care Volume 22, 2004 - Issue 1
Submit an article Journal homepage
1,072
Views
61
CrossRef citations to date
0
Altmetric
Original Paper

Gender differences in risk factor control and treatment profile in diabetes: a study in 229 Swedish primary health care centres

Peter M Nilsson Department of Medicine, University Hospital, Malmö, SwedenCorrespondence[email protected]
,
Holger Theobald Department of Family Medicine, Karolinska Institute, Huddinge, Sweden
,
Gunilla Journath Merck Sharp & Dohme (Sweden) AB, Sollentuna, Sweden
&
Tomas Fritz Gustavsberg Primary Health Care Centre, Gustavsberg, Sweden
Pages 27-31 | Published online: 12 Jul 2009

References

  • Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross-sectional study. BMJ 2001;322:832–4.
  • Majeed FA, Cook DG. Age and sex differences in the management of ischaemic heart disease. Public Health 1996;110:7–12.
  • Nilsson P, Brandstrom H, Lingfors H, Israelsson B, Hed-back B, Sjoberg G, et al. Gender differences in secondary prevention: reasons to worry or not? Scand J Prim Health Care 2003;21:37–42.
  • Siann T, Duncan EM, Sullivan F, Matthews D, Cromie DT. Area-wide diabetes care: the Lanarkshire experience with primary health care teams 1994–1997. Diabetic Med 1998;15\(Suppl 3):554–7.
  • Diabetes care and research in Europe: the Saint Vincent Declaration. Diabetic Med 1989;7:360.
  • Nilsson PM, Gudbjörnsdottir S, Eliasson B, Cederholm J. for the Steering Committee of the National Diabetes Register, Sweden. Hypertension in diabetes: trends in control and relation to macrovascular morbidity in repeated national surveys from Sweden. J Hum Hypertens 2003;17:37–44.
  • Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B. for the Steering Committee of the Swedish National Diabetes Register. The National Diabetes Register (NDR) in Sweden: An Implementation of the St. Vincent Declara-tion for Quality Improvement in Diabetes Care. Diabetes Care 2003;26:1270–6.
  • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a rando-mised placebo-controlled trial. Heart Protection Study Collaborative Group. Lancet 2002;360:7–22.
  • Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care 2000;23:888–92.
  • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Out-comes Prevention Evaluation Study Investigators. Lancet 2000;355:253–9.
  • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 2002;25(Suppl 1):S1–147.
  • Nationella riktlinjer for diabetes. (National guidelines for Diabetes management). (Summary in English). National Board of Health and Welfare. Stockholm, 2001.
  • Landin B. Korrekta nivä.er av HbAie (Correct levels of HbAie). Laboratory Medicine 1998:1, Huddinge University Hospital, Stockholm, 1998.
  • Gami AS, Montori VM, Erwin PJ, Khan MA, Smith SA. Evidence in Diabetes Enquiry System (EVIDENS) Re-search Group. Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes. BMJ 2003;326:528–9.
  • Wändell PE, Gäfvels C. Metabolic control and quality of data in medical records for subjects with type 2 diabetes in Swedish primary care: improvements between 1995 and 2001. Scand J Prim Health Care 2002;20:230–5.
  • Wändell PE, Brorsson B, Aberg H. Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - change over time. Eur J Clin Pharmacol 1997;52: 249–54.
  • Os I, Bratland B, Dahlöf B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994;7:1012–5.
  • Jonsson PM, Sterky G, Gdfvels C, Ostman J. Gender equity in health care: the case of Swedish diabetes care. Health Care Women Int 2000;21:413–31.
  • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837–53.
  • Fitzgerald JT, Anderson RM, Davis WK. Gender differ-ences in diabetes attitudes and adherence. Diabetes Educ 1995;21:523–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.